NEW YORK (GenomeWeb News) – BioSeek said today that it has expanded an agreement with the Environmental Protection Agency, under which EPA will use the firm's BioMap in the second phase of its ToxCast program.

Under the agreement, EPA will use the BioMap, which employs cell-based disease models to generate activity profiles of potential drugs, to study the biological effects of certain chemicals and help the agency select new candidates. BioSeek also will use its technology to assess the impact of these chemicals on the environment and on human health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.